Document is current
Any future updates will be listed below
-
Authors
Mészáros, Ádám
Molnár, Kinga
Fazakas, Csilla
Nógrádi, Bernát
Lüvi, Adél
Dudás, Tamás
Tiszlavicz, László
Farkas, Attila Elek
Krizbai, István Adorján
Wilhelm, Imola http://orcid.org/0000-0003-2366-7337
-
Funding
Funding for this research was provided by:
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (K135425, TKP2021-EGA-09, K135475, FK132638)
Magyar Tudományos Akadémia (NAP2022-I-6, BO/00213/19/8)
Eötvös Loránd Research Network (SA-73/2021)
Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (PN-III-P4-ID-PCE-2020-1529)
Innovációs és Technológiai Minisztérium (VI/1697-4/2022/FÁFIN)
Richter Gedeon Talentum Alapítvány (PhD Scholarship)
ELKH Biological Research Center
- License Information
-
More Information
Article History
Received: 6 July 2023
Accepted: 27 August 2023
First Online: 25 September 2023
Declarations
:
: Treatment of mice conformed fully to ARRIVE 2.0 Guidelines and Hungarian governmental laws for the protection of animals used for scientific purposes. All experimental procedures performed in this study were approved by the Regional Animal Health and Food Control Station of Csongrád-Csanád County (License Number: XVI./764/2018, issued on May 4, 2018). Details on the ARRIVE Essential 10 items are included in “InternalRef removed” section and in the figure legends. Human samples were collected in accordance with the approval of the Human Investigation Review Board, University of Szeged (License Numbers: EMLOSEB001, issued on January 31, 2017 and 172/2022-SZTE RKEB, issued on November 22, 2021), as well as in compliance with the Ethical Principles for Medical Research Involving Human Subjects (World Medical Association Declaration of Helsinki). Patients involved in the study provided informed consent for the use of their material.
: The authors declare that they have no competing interests.
